Correction: Corrigendum: Recessive tolerance to preproinsulin 2 reduces but does not abolish type 1 diabetes

被引：0
|
作者：
Elmar Jaeckel
Myra A Lipes
Harald von Boehmer
机构：
来源：
Nature Immunology | 2004年 / 5卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Nature Immunology 5, 1028–1035 (2003). On page 1034, line 12, reference 40 should be reference 37.
引用
收藏
页码：1190 / 1190
相关论文
共 50 条
  • [41] Correction to: Dapagliflozin: A Review in Type 1 Diabetes
    Julia Paik
    Hannah A. Blair
    Drugs, 2019, 79 (18) : 2011 - 2011
  • [42] Cytotoxic preproinsulin-specific CD8 T cells in type 1 diabetes in man
    Skowera, Anna
    Ellis, Richard
    Tree, Timothy
    Peakman, Mark
    Arif, Sefina
    CLINICAL IMMUNOLOGY, 2007, 123 : S10 - S10
  • [43] A RARE CASE OF RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA AND TYPE 1 DIABETES
    Plevey, K. E.
    Petrof, G.
    Martinez, A. E.
    ACTA DERMATO-VENEREOLOGICA, 2020, 100 : 29 - 29
  • [44] Preproinsulin specific T cell lines in type 1 diabetes: Characterization of their cytokine profile and epitope specificity
    Rosinger, S
    Durinovic-Bello, I
    Kalbacher, H
    Boehm, BO
    DIABETES, 2000, 49 : A235 - A235
  • [45] Bread in type 2 diabetes: does the type matter?
    Breen, C.
    O'Shea, D.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2010, 179 : 535 - 535
  • [46] Risk factors associated with type 2 diabetes in youngsters with type 1A(Autoimmune) diabetes: Does it matter?
    Libman, I
    Pietropaolo, M
    Arslanian, S
    Laporte, R
    Becker, D
    DIABETES, 2001, 50 : A39 - A40
  • [47] Tolerance to Proinsulin-1 Reduces Autoimmune Diabetes in NOD Mice
    Jhala, Gaurang
    Selck, Claudia
    Chee, Jonathan
    Kwong, Chun-Ting J.
    Pappas, Evan G.
    Thomas, Helen E.
    Kay, Thomas W. H.
    Krishnamurthy, Balasubramanian
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [48] Circulating Ism1 Reduces the Risk of Type 2 Diabetes but not Diabetes-Associated NAFLD
    Wang, Jiajia
    Du, Juan
    Ge, Xiaoxu
    Peng, Wenfang
    Guo, Xirong
    Li, Wenyi
    Huang, Shan
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [49] Treatment with acarbose reduces postprandial hyperglycemia in subjects with impaired glucose tolerance or early untreated type 2 diabetes
    Byrne, MM
    Burhorn, M
    Goeke, B
    DIABETES, 2000, 49 : A341 - A341
  • [50] Correction to: Dapagliflozin: A Review in Type 2 Diabetes
    Sohita Dhillon
    Drugs, 2019, 79 (18) : 2013 - 2013
12345